BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23520464)

  • 1. Common single nucleotide polymorphisms in genes related to immune function and risk of papillary thyroid cancer.
    Brenner AV; Neta G; Sturgis EM; Pfeiffer RM; Hutchinson A; Yeager M; Xu L; Zhou C; Wheeler W; Tucker MA; Chanock SJ; Sigurdson AJ
    PLoS One; 2013; 8(3):e57243. PubMed ID: 23520464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.
    Sigurdson AJ; Brenner AV; Roach JA; Goudeva L; Müller JA; Nerlich K; Reiners C; Schwab R; Pfeiffer L; Waldenberger M; Braganza M; Xu L; Sturgis EM; Yeager M; Chanock SJ; Pfeiffer RM; Abend M; Port M
    Carcinogenesis; 2016 Jul; 37(7):677-684. PubMed ID: 27207655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common genetic variants in sex hormone pathway genes and papillary thyroid cancer risk.
    Schonfeld SJ; Neta G; Sturgis EM; Pfeiffer RM; Hutchinson AA; Xu L; Wheeler W; Guénel P; Rajaraman P; de Vathaire F; Ron E; Tucker MA; Chanock SJ; Sigurdson AJ; Brenner AV
    Thyroid; 2012 Feb; 22(2):151-6. PubMed ID: 22224819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common genetic variants in the 8q24 region and risk of papillary thyroid cancer.
    Neta G; Yu CL; Brenner A; Gu F; Hutchinson A; Pfeiffer R; Sturgis EM; Xu L; Linet MS; Alexander BH; Chanock S; Sigurdson AJ
    Laryngoscope; 2012 May; 122(5):1040-2. PubMed ID: 22275265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common genetic variants in metabolism and detoxification pathways and the risk of papillary thyroid cancer.
    Aschebrook-Kilfoy B; Neta G; Brenner AV; Hutchinson A; Pfeiffer RM; Sturgis EM; Xu L; Wheeler W; Doody MM; Chanock SJ; Sigurdson AJ
    Endocr Relat Cancer; 2012 Jun; 19(3):333-44. PubMed ID: 22389382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common genetic variants related to genomic integrity and risk of papillary thyroid cancer.
    Neta G; Brenner AV; Sturgis EM; Pfeiffer RM; Hutchinson AA; Aschebrook-Kilfoy B; Yeager M; Xu L; Wheeler W; Abend M; Ron E; Tucker MA; Chanock SJ; Sigurdson AJ
    Carcinogenesis; 2011 Aug; 32(8):1231-7. PubMed ID: 21642358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
    Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
    Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation the Presence of SERPINA5 (Exon 3) and FTO rs9939609 Polymorphisms in Papillary Thyroid Cancer Patients.
    Moshtaghioun SM; Fazel-Yazdi N; Mandegari M; Shirinzadeh-Dastgiri A; Vakili M; Fazel-Yazdi H
    Asian Pac J Cancer Prev; 2021 Nov; 22(11):3641-3646. PubMed ID: 34837923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.
    Wei WJ; Lu ZW; Wang Y; Zhu YX; Wang YL; Ji QH
    Cancer Genet; 2015 Mar; 208(3):68-75. PubMed ID: 25746573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.
    Wang YL; Feng SH; Guo SC; Wei WJ; Li DS; Wang Y; Wang X; Wang ZY; Ma YY; Jin L; Ji QH; Wang JC
    J Med Genet; 2013 Oct; 50(10):689-95. PubMed ID: 23847140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
    Dong G; Zhang R; Xu J; Guo Y
    Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
    Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
    Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single nucleotide polymorphisms of the Fas gene are associated with papillary thyroid cancer.
    Eun YG; Lee YC; Kim SK; Chung JH; Kwon KH; Park IS
    Auris Nasus Larynx; 2015 Aug; 42(4):326-31. PubMed ID: 25824544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population.
    Kim SK; Park HJ; Hong IK; Chung JH; Eun YG
    Endocrine; 2013 Feb; 43(1):161-9. PubMed ID: 23124277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common obesity-related genetic variants and papillary thyroid cancer risk.
    Kitahara CM; Neta G; Pfeiffer RM; Kwon D; Xu L; Freedman ND; Hutchinson AA; Chanock SJ; Sturgis EM; Sigurdson AJ; Brenner AV
    Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2268-71. PubMed ID: 23064004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.
    Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH
    Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer.
    Çil E; Kumral A; Kanmaz-Özer M; Vural P; Doğru-Abbasoğlu S; Altuntaş Y; Uysal M
    Mol Biol Rep; 2014 May; 41(5):3091-7. PubMed ID: 24464184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation of MAPK signal-inhibiting genes in papillary thyroid carcinoma.
    Lee EK; Chung KW; Yang SK; Park MJ; Min HS; Kim SW; Kang HS
    Anticancer Res; 2013 Nov; 33(11):4833-9. PubMed ID: 24222120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 22 polymorphisms and papillary thyroid cancer.
    Eun YG; Shin IH; Lee YC; Shin SY; Kim SK; Chung JH; Kwon KH
    J Endocrinol Invest; 2013 Sep; 36(8):584-7. PubMed ID: 23448944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population.
    Park SW; Kim MK; Kwon KH; Kim J
    Int J Immunogenet; 2012 Dec; 39(6):501-7. PubMed ID: 22594576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.